$DTIL
PRECISION BIOSCIENCES INC

2022 Q1 Form 10-Q Financial Statement

#000156459022018698 Filed on May 09, 2022

View on sec.gov

Income Statement

Concept 2022 Q1 2021 Q1
Revenue $3.317M $16.35M
YoY Change -79.71% 133.57%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $10.69M $9.500M
YoY Change 12.54% -1.25%
% of Gross Profit
Research & Development $19.97M $25.59M
YoY Change -21.96% 11.08%
% of Gross Profit
Depreciation & Amortization $1.968M $2.180M
YoY Change -9.72% 0.93%
% of Gross Profit
Operating Expenses $19.97M $25.59M
YoY Change -21.96% -25.8%
Operating Profit -$27.34M
YoY Change
Interest Expense -$822.0K $50.00K
YoY Change -1744.0% -92.42%
% of Operating Profit
Other Income/Expense, Net -$833.0K
YoY Change
Pretax Income -$28.17M -$18.69M
YoY Change 50.71% -30.37%
Income Tax
% Of Pretax Income
Net Earnings -$28.17M -$18.69M
YoY Change 50.72% -30.36%
Net Earnings / Revenue -849.2% -114.31%
Basic Earnings Per Share -$0.46
Diluted Earnings Per Share -$461.5K -$330.0K
COMMON SHARES
Basic Shares Outstanding 61.03M
Diluted Shares Outstanding 61.03M

Balance Sheet

Concept 2022 Q1 2021 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $116.2M $193.5M
YoY Change -39.94% 25.49%
Cash & Equivalents $116.2M $193.5M
Short-Term Investments
Other Short-Term Assets $17.34M $6.400M
YoY Change 170.98% -27.27%
Inventory
Prepaid Expenses
Receivables $488.0K $19.30M
Other Receivables $0.00 $0.00
Total Short-Term Assets $134.1M $219.1M
YoY Change -38.82% 31.35%
LONG-TERM ASSETS
Property, Plant & Equipment $27.77M $40.00M
YoY Change -30.59% -11.89%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $5.890M
YoY Change
Other Assets $4.655M $1.800M
YoY Change 158.61% 200.0%
Total Long-Term Assets $47.30M $43.20M
YoY Change 9.49% -8.86%
TOTAL ASSETS
Total Short-Term Assets $134.1M $219.1M
Total Long-Term Assets $47.30M $43.20M
Total Assets $181.4M $262.3M
YoY Change -30.86% 22.46%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $699.0K $400.0K
YoY Change 74.75% -77.78%
Accrued Expenses $7.101M $8.200M
YoY Change -13.4% -5.75%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $29.11M $63.80M
YoY Change -54.38% 168.07%
LONG-TERM LIABILITIES
Long-Term Debt $2.482M $0.00
YoY Change
Other Long-Term Liabilities $80.10M $392.0K
YoY Change 20334.69% -99.48%
Total Long-Term Liabilities $82.59M $392.0K
YoY Change 20967.86% -99.48%
TOTAL LIABILITIES
Total Short-Term Liabilities $29.11M $63.80M
Total Long-Term Liabilities $82.59M $392.0K
Total Liabilities $111.7M $203.5M
YoY Change -45.11% 105.14%
SHAREHOLDERS EQUITY
Retained Earnings -$304.8M
YoY Change
Common Stock $364.5M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost) $952.0K
YoY Change
Treasury Stock Shares
Shareholders Equity $69.66M $58.82M
YoY Change
Total Liabilities & Shareholders Equity $181.4M $262.3M
YoY Change -30.87% 22.46%

Cashflow Statement

Concept 2022 Q1 2021 Q1
OPERATING ACTIVITIES
Net Income -$28.17M -$18.69M
YoY Change 50.72% -30.36%
Depreciation, Depletion And Amortization $1.968M $2.180M
YoY Change -9.72% 0.93%
Cash From Operating Activities -$28.87M $68.07M
YoY Change -142.41% -362.72%
INVESTING ACTIVITIES
Capital Expenditures -$818.0K -$1.130M
YoY Change -27.61% 2.73%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$818.0K -$1.125M
YoY Change -27.29% 1.99%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $1.627M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 2.249M 36.72M
YoY Change -93.87% 11592.68%
NET CHANGE
Cash From Operating Activities -28.87M 68.07M
Cash From Investing Activities -818.0K -1.125M
Cash From Financing Activities 2.249M 36.72M
Net Change In Cash -28.87M 103.7M
YoY Change -127.85% -488.26%
FREE CASH FLOW
Cash From Operating Activities -$28.87M $68.07M
Capital Expenditures -$818.0K -$1.130M
Free Cash Flow -$28.05M $69.20M
YoY Change -140.54% -378.93%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y29D
CY2021Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y5M4D
CY2021Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
25593000
CY2021Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
9498000
CY2022Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
19972000
CY2022Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-952000
CY2021Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1297000
CY2021Q1 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
418000
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3632000
CY2021Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
619000
CY2021Q1 dtil Stock Issued During Period Value Collaboration Partners
StockIssuedDuringPeriodValueCollaborationPartners
27739000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-18689000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
91168000
CY2022Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
340000
CY2022Q1 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
282000
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4390000
CY2022Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
1647000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-28168000
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
69659000
CY2022Q1 us-gaap Profit Loss
ProfitLoss
-28168000
CY2022Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1968000
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
4390000
CY2022Q1 us-gaap Gains Losses On Sales Of Assets
GainsLossesOnSalesOfAssets
-11000
CY2022Q1 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
17000
CY2022Q1 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
288000
CY2021Q1 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
290000
CY2022Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-952000
CY2022Q1 dtil Amortization Of Discount On Note Receivable
AmortizationOfDiscountOnNoteReceivable
87000
CY2022Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-374000
CY2021Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
9263000
CY2021Q1 dtil Increase Decrease In Other Assets And Other Current Assets
IncreaseDecreaseInOtherAssetsAndOtherCurrentAssets
6000
CY2021Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
221000
CY2021Q1 dtil Increase Decrease In Accrued Other Expenses And Other Current Liabilities
IncreaseDecreaseInAccruedOtherExpensesAndOtherCurrentLiabilities
-2146000
CY2021Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
92914000
CY2022Q1 dtil Increase Decrease In Lease Liability And Right To Use Asset Other Than Amortization Net
IncreaseDecreaseInLeaseLiabilityAndRightToUseAssetOtherThanAmortizationNet
434000
CY2021Q1 dtil Increase Decrease In Lease Liability And Right To Use Asset Other Than Amortization Net
IncreaseDecreaseInLeaseLiabilityAndRightToUseAssetOtherThanAmortizationNet
461000
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-28872000
CY2021Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
68072000
CY2022Q1 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
818000
CY2021Q1 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
1125000
CY2021Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1125000
CY2021Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1297000
CY2022Q1 dtil Proceeds From Employee Stock Purchase Plan
ProceedsFromEmployeeStockPurchasePlan
282000
CY2021Q1 dtil Proceeds From Employee Stock Purchase Plan
ProceedsFromEmployeeStockPurchasePlan
418000
CY2021Q1 us-gaap Proceeds From Minority Shareholders
ProceedsFromMinorityShareholders
35000000
CY2022Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
1627000
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
193460000
CY2022Q1 dei Entity Incorporation Date Of Incorporation
EntityIncorporationDateOfIncorporation
2006-01-26
CY2022Q1 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
3300000
CY2022Q1 dtil Unsettled At The Market Issuances Of Common Stock Included In Other Current Assets
UnsettledAtTheMarketIssuancesOfCommonStockIncludedInOtherCurrentAssets
217000
CY2019Q2 dtil Common And Preferred Stocks Shares Authorized
CommonAndPreferredStocksSharesAuthorized
210000000
CY2019Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2019Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.000005
CY2019Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2019Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
4390000
CY2021Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3632000
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.0000
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.0000
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.7847
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.7369
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
1594000
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0185
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0066
CY2022Q1 dtil Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Fair Value Per Option
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageFairValuePerOption
2.73
CY2021Q1 dtil Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Fair Value Per Option
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageFairValuePerOption
8.32
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
9920314
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
9.28
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
2938074
CY2022Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
3.98
CY2022Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
233001
CY2022Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
1.46
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
739815
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
10.00
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
11885572
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
8.08
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
500000
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
6800000
CY2022Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
43200000
CY2022Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y9M18D
CY2022Q1 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
0
CY2021Q4 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
0
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
1703000
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
2323000
CY2022Q1 us-gaap Debt Instrument Interest Rate Effective Percentage
DebtInstrumentInterestRateEffectivePercentage
0.0703
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
529000
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
545000
CY2022Q1 dtil Lessee Operating Lease Liability Payments Due In Five Years And Thereafter
LesseeOperatingLeaseLiabilityPaymentsDueInFiveYearsAndThereafter
372000
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
7066000
CY2022Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
865000
CY2022Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
6201000
CY2022Q1 us-gaap Debt Instrument Interest Rate Stated Percentage
DebtInstrumentInterestRateStatedPercentage
0.0625
CY2022Q1 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-28168000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-18689000
CY2022Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
61031775
CY2021Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
56625024
CY2022Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.46
CY2021Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.33
CY2022Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2603213
CY2021Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
7670256
CY2022Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1

Files In Submission

Name View Source Status
0001564590-22-018698-index-headers.html Edgar Link pending
0001564590-22-018698-index.html Edgar Link pending
0001564590-22-018698.txt Edgar Link pending
0001564590-22-018698-xbrl.zip Edgar Link pending
dtil-10q_20220331.htm Edgar Link pending
dtil-10q_20220331_htm.xml Edgar Link completed
dtil-20220331.xsd Edgar Link pending
dtil-20220331_cal.xml Edgar Link unprocessable
dtil-20220331_def.xml Edgar Link unprocessable
dtil-20220331_lab.xml Edgar Link unprocessable
dtil-20220331_pre.xml Edgar Link unprocessable
dtil-ex311_38.htm Edgar Link pending
dtil-ex312_37.htm Edgar Link pending
dtil-ex321_35.htm Edgar Link pending
dtil-ex322_36.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending